Vaso Corporation reported third‑quarter 2025 revenue of $22.7 million, a 9.1% year‑over‑year increase from $20.8 million in the same quarter of 2024. Net income flipped to $1.7 million from a $1.2 million loss in Q3 2024, driven by higher gross profit and tighter operating costs across all three business segments.
The professional sales‑service segment led the top‑line growth, posting $1.7 million in revenue—an 18.7% rise—thanks to a surge in GE Healthcare equipment deliveries. The IT segment added $136 thousand, a 1.2% increase, largely from network‑services contracts, while the equipment segment grew $46 thousand, an 8.0% gain, powered by stronger ARCS software subscription sales in the United States.
Gross profit climbed to $13.9 million, up 18.2% from $11.8 million in Q3 2024, reflecting a shift toward higher‑margin subscription revenue and improved cost control. SG&A expenses rose 7% to $12.2 million, and operating income turned positive at $1.5 million versus a $1.4 million loss the prior year. Adjusted EBITDA improved to $1.6 million from a negative $1.2 million, and operating cash flow was $2.8 million. Cash and cash equivalents stood at $34.9 million, underscoring a solid liquidity position.
Dr. Jun Ma, President and CEO, highlighted that all three segments contributed to the revenue increase and expressed confidence in a stable topline, citing the upward trend in deferred revenue and subscription sales. He noted that the company’s balance sheet remains strong, with significant cash reserves to support future growth.
The results signal a successful shift toward recurring revenue and stronger profitability. The turnaround from a net loss to a profit, coupled with rising gross margins and positive cash flow, suggests that Vaso’s strategic focus on managed IT services and subscription‑based medical‑device software is beginning to pay off. The robust cash balance and growing deferred‑revenue backlog provide a buffer for continued investment and potential expansion in the coming quarters.
No forward‑looking guidance was disclosed in the earnings release, and the company did not report any specific challenges for the quarter.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.